Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
 Disease Category: Rheumatoid Arthritis
Location: United States, NY

Trial Information

Rheumatoid Arthritis

The purpose of this research study is to assess the safety and effectiveness of 2 different doses of an investigational, anti-inflammatory, oral medication for rheumatoid arthritis. The study medication will be compared to a placebo, an inactive substance. Depending upon which dose you randomly receive at the beginning of the study, your study participation will either involve 5 office visits and 1 phone call over 10 weeks, or 7 visits and 1 phone call over 16 weeks. At the first visit you will read and sign an informed consent document and have an opportunity to ask questions before participating in the study. A study-related physical exam, vital signs, height and weight, EKG, urinalysis, and non-fasting lab tests will be performed. You will be allowed to continue your routine medications for rheumatoid arthritis, but after signing consent at your first visit, you will be asked to stop any anti-inflammatory pain medications, except low-dose aspirin. You will be provided with Tylenol® for breakthrough pain. All study-related procedures, physical exams, the Tylenol® and study drug are at no cost to you. You will be compensated for your time and travel at $40.00 per completed visit. You will not be compensated for phone calls.

For more information and to see if you pre-qualify, please call our office or visit our website at www.rcrclinical.com.

Rochester Clinical Research
500 Helendale Road, Suite L20
Rochester, NY 14609
Phone: 585.288.0890

View Map

Research Center Information: Rochester Clinical Research

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.